October 2017

  • The Incomplete Report

    Among the many affected by cholera throughout Yemen, these infected children lie on the ground in a hospital in Sanaa. Photo: KHALED ABDULLAH/REUTERS/Newscom
    Among the many affected by cholera throughout Yemen, these infected children lie on the ground in a hospital in Sanaa. Photo: KHALED ABDULLAH/REUTERS/Newscom

    An article in the World Health Organization (WHO) August Weekly Epidemiological Record (WER) reported that since the creation of the global stockpile for oral cholera vaccine (OCV) in 2013, 55 campaigns have been conducted using nearly 13 million doses [1]. A majority of the OCV doses (73%), were used in emergency settings, while 27% were used in non-emergency settings to control endemic cholera. The report described OCV deployments in terms of the setting, targeted populations, campaign timelines, and coverage. The increasing trend in OCV use in affected countries is an achievement that the WHO can be proud of.

  • Oral Cholera Vaccine Recommendations through the Years

    Anna Lena Lopez, MD

    Research Associate Professor | Inst. of Child Health & Human Development, Univ. of the Philippines Manila-National Inst. of Health
    Three-year-old Salomon looks on as he undergoes treatment for cholera at the general hospital in Minova. Photo: Arjun Claire
    Three-year-old Salomon looks on as he undergoes treatment for cholera at the general hospital in Minova. Photo: Arjun Claire

    On April 25-27, 2017, the World Health Organization (WHO) Strategic Advisory Group of Experts (SAGE) on vaccines and immunization took up oral cholera vaccination during its meeting, with a view of updating the 2010 WHO position paper [1]. WHO regularly releases position papers to guide member states on vaccines and immunization that have global public health importance.